publication date: Dec. 19, 2010
In this issue:
White House preparing to nominate Andrew von Eschenbach as FDA commissioner, sources said.
FDA approves Erbitux for head & neck cancer.
Nancy Davidson elected ASCO president.
NCI releases list of cancer center core grant funding for FY 2005; Univ. of New Mexico is the newest NCI-designated center.
At AAAS meeting, David Baltimore comments on Bush administration science policy.
Download (PDF 818KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.